Clinical Trial Update: Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating treatment for paradoxical TB-IRIS has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Immune Reconstitution Inflammatory Syndrome
• Tuberculosis

Snippet

Sponsor: University of Minnesota | Conditions: Immune Reconstitution Inflammatory Syndrome, Immune Reconstitution Syndrome | Phase 2, Phase 3 | Status: WITHDRAWN